GlassScriptPhysician profile
Mandar A Aras
NPI 1720377146
$40,944.19
in general payments reported to CMS, 2019-2025
21 companies · $3,341 in 2025
The $3,341 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,138 · 2020: $144 · 2021: $49.52 · 2022: $3,056 · 2023: $18K · 2024: $15K · 2025: $3,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Grant: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,520 · Travel and Lodging: $2,048 · Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,686.25 |
| Grant | $10,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,520.00 |
| Travel and Lodging | $2,047.71 |
| Food and Beverage | $1,302.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20,422.72 | 2023-2024 | |
| Pfizer INC. | $12,207.90 | 2019-2024 | |
| Alnylam Pharmaceuticals INC. | $3,453.22 | 2019-2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $2,120.16 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $1,460.00 | 2022-2023 | |
| Medtronic Vascular, INC. | $494.12 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $348.01 | 2019-2024 | |
| Amgen INC. | $165.04 | 2024 | Repatha |
| Boston Scientific Corporation | $144.09 | 2020 | |
| Paragonix Technologies, INC. | $40.85 | 2023 | Paragonix Sherpapak Cardiac Transport System, Sherpacool Box, Cts Canister Box |
| Endotronix, INC. | $38.93 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Livanova USA, INC. | $22.31 | 2021 | |
| United Therapeutics Corporation | $21.84 | 2019 | |
| Nuwellis, INC. | $5.00 | 2023 | Aquadex Smartflow Console |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandar Aras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.